Safely Buy Bevespi Aerosphere ( Glycopyrrolate/Formoterol Fumarate ) from Canada Prescriptions Plus.

( Top Brand Option )

Bevespi Aerosphere

Prescription Required
Formulation : Aerosol
Drug Name Dosage Quantity Price Buy Now
Bevespi Aerosphere 9/4.8mcg 120doses $450.20 Add To Cart
Bevespi Aerosphere
Dosage: 9/4.8mcg
Quantity: 120doses
Price: $450.20

( Affordable Generic Alternatives )

Glycopyrrolate/Formoterol Fumarate

Prescription Required
Formulation : Aerosol
Drug Name Dosage Quantity Price Buy Now
Glycopyrrolate/Formoterol Fumarate 9/4.8mcg 120doses $50.55 Add To Cart
Glycopyrrolate/Formoterol Fumarate 9/4.8mcg 360doses $117.35 Add To Cart
Glycopyrrolate/Formoterol Fumarate
Dosage: 9/4.8mcg
Quantity: 120doses
Price: $50.55
Glycopyrrolate/Formoterol Fumarate
Dosage: 9/4.8mcg
Quantity: 360doses
Price: $117.35

Indications

Bevespi Aerosphere is a prescription medicine used to treat chronic obstructive pulmonary disease (COPD) in adults. COPD includes chronic bronchitis, emphysema, or both.

Bevespi Aerosphere contains two active ingredients: glycopyrrolate and formoterol fumarate. Glycopyrrolate is a long-acting muscarinic antagonist (LAMA) that helps to relax the muscles in the airways and improve breathing.

Formoterol fumarate is a long-acting beta2-adrenergic agonist (LABA) that also helps to relax the muscles in the airways and improve breathing.

Bevespi Aerosphere is typically prescribed as a maintenance bronchodilator treatment to relieve symptoms in adult patients with COPD.

Use and Dosage

Recommended Dosage and Administration

  • The recommended dosage of BEVESPI AEROSPHERE is glycopyrrolate 18 mcg and formoterol fumarate 9.6 mcg (administered as two inhalations of BEVESPI AEROSPHERE [glycopyrrolate/formoterol fumarate 9 mcg/4.8 mcg]) twice daily in the morning and in the evening by oral inhalation. Do not take more than two inhalations twice daily.

Preparation

  • Priming BEVESPI AEROSPHERE is essential to ensure appropriate drug content in each actuation. To prime BEVESPI AEROSPHERE, release 4 sprays into the air away from the face, shaking well before each spray. BEVESPI AEROSPHERE must be re-primed when the inhaler has not been used for more than 7 days. To re-prime BEVESPI AEROSPHERE, release 2 sprays into the air away from the face, shaking well before each spray.

Dose Counter

  • The canister has an attached dose indicator, which indicates how many inhalations remain. The dose indicator display will move after every tenth actuation. When nearing the end of the usable inhalations, the colour behind the number in the dose indicator display window changes to red. BEVESPI AEROSPHERE should be discarded when the dose indicator display window shows zero.

Side Effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Serious side effects include:

  • Tremors, nervousness, chest pain, fast or pounding heartbeats
  • Wheezing, choking, or other breathing problems after using this medicine
  • Painful or difficult urination
  • Blurred vision, tunnel vision, eye pain or redness, or seeing halos around lights
  • High blood sugar: increased thirst, increased urination, dry mouth, fruity breath odor
  • Low potassium level: leg cramps, constipation, irregular heartbeats, fluttering in your chest, numbness or tingling, muscle weakness or limp feeling

Common side effects include:

  • Cough
  • Urination problems

This is not a complete list of side effects and others may occur.

Cautions

You should not use this medicine if you are allergic to formoterol or glycopyrrolate. This medicine is for use only in people with COPD and should not be used to treat asthma.

Tell your doctor if you have ever had:

  • Heart disease, high blood pressure
  • A seizure
  • Liver disease
  • Glaucoma
  • Diabetes
  • A thyroid disorder
  • Urination problems
  • Any food or drug allergies

Tell your doctor if you are pregnant or breastfeeding.

This medicine is not approved for use by anyone younger than 18 years old.

Form and Strengths

Bevespi Aerosphere is available in the following form and strengths:

  • Bevespi Aerosphere Aerosol:
    • 9/4.8 mcg
  • Glycopyrrolate/Formoterol Fumarate Aerosol:
    • 9/4.8 mcg

FAQ

What happens if I miss a dose?

Skip the missed dose and use your next dose at the regular time. Do not use two doses at one time.

What happens if I overdose?

Seek emergency medical attention. Overdose can cause vomiting, severe constipation, blurred vision, chest pain, heart problems, or fainting.

What should I avoid while using formoterol and glycopyrrolate?

If formoterol and glycopyrrolate get in your eyes, rinse them with water and call your doctor if you have ongoing eye redness even after rinsing.

Do not use a second inhaled bronchodilator that contains formoterol or a similar medicine (such as arformoterol, indacaterol, olodaterol, salmeterol, or vilanterol).

Resources:

  1. https://pubmed.ncbi.nlm.nih.gov/29567116/
  2. https://www.drugs.com/mtm/formoterol-and-glycopyrrolate.html#before-taking
  3. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208294s000lbl.pdf

Additional information

Brand Name:

Bevespi Aerosphere

Scientific Name:

Glycopyrrolate/Formoterol Fumarate

Other Names:

Bevespi Aerosphere, Forglyn Inhaler

Strength(s):

9/4.8mcg

Quantities Available:

120doses, 360doses

Formulation:

Aerosol